Work

“formulation, Characterization and in Vitro Evaluation of Betulinic Acid-loaded Lipid Nanocarriers for Enhanced Bioavailability and Sustained Release in Lung Cancer Therapy”

Year: 2025
Type: article
Abstract: Betulinic Acid, a bioactive compound with significant anticancer potential, suffers from poor solubility and low bioavailability, limiting its therapeutic efficacy. This study aimed to develop Betulinic Acid-loaded lipid nanocarriers (BALNCs) to enhance drug solubility, bioaccessibility, and controlled release. With particle diameters between 42 and 44 nm, a polydispersity index (PDI) of approximately 0.26, and a zeta potential of approximately 20 mV, the nanocarriers were effectively synthesised and characterised, guaranteeing stability.
Language: English
Subfield: Biomaterials
Open Access status: hybrid
OpenAlex ID: W6929092572
FWCI:
Cites: 1
Cited by:
Related to: